← Back to Search

Herbal Medicine

Herbal Pain Relief Patch for Cancer-related Pain

Phase 2
Waitlist Available
Led By Jun Mao, MD, MSCE
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Having a focused location of regional musculoskeletal pain (e.g. joints, extremities, back, neck) that can be covered by one patch of PRP
Patients currently have no evidence of disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days from baseline
Awards & highlights

Study Summary

This trial will test whether the Tibetree Pain Relieving Plaster can help cancer patients with pain.

Who is the study for?
This trial is for adults over 18 who are cancer survivors in remission, experiencing musculoskeletal pain for at least 3 months. They must have completed active cancer treatment at least a month ago but can be on hormone or maintenance therapies. Participants need to have a focused area of pain that can be covered by the patch and not suffer from generalized pain conditions like fibromyalgia.Check my eligibility
What is being tested?
The study tests Tibetree Pain Relieving Plaster, an herbal patch designed for temporary relief of minor muscle and joint pains, against a placebo. This is its first test among people who've had cancer to see if it reduces their pain effectively.See study design
What are the potential side effects?
While specific side effects aren't listed, potential risks may include skin irritation or allergic reactions due to the adhesive or herbal components in the Tibetree Pain Relieving Plaster.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have pain in one area of my muscles or joints that can be treated with a single patch.
Select...
My current tests show no signs of cancer.
Select...
I am 18 years old or older.
Select...
My worst pain level was 5 or higher last week.
Select...
I can take care of myself but may need occasional help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Pain Inventory - Measure of Participant Pain

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Tibetree pain relieving plasterExperimental Treatment1 Intervention
Participants with chronic musculoskeletal pain for ≥ 3 months and with BPI worst pain rated 5 or greater during the preceding week will be eligible for the study. We will enroll 66 participants with 33 patients in each arm.
Group II: Placebo plaster groupsPlacebo Group1 Intervention
Participants with chronic musculoskeletal pain for ≥ 3 months and with BPI worst pain rated 5 or greater during the preceding week will be eligible for the study. We will enroll 66 participants with 33 patients in each arm.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,928 Previous Clinical Trials
591,739 Total Patients Enrolled
Jun Mao, MD, MSCEPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
9 Previous Clinical Trials
1,916 Total Patients Enrolled

Media Library

Tibetree Pain Relieving Plaster (Herbal Medicine) Clinical Trial Eligibility Overview. Trial Name: NCT04916249 — Phase 2
Cancer Research Study Groups: Tibetree pain relieving plaster, Placebo plaster groups
Cancer Clinical Trial 2023: Tibetree Pain Relieving Plaster Highlights & Side Effects. Trial Name: NCT04916249 — Phase 2
Tibetree Pain Relieving Plaster (Herbal Medicine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04916249 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations are currently conducting this experiment?

"At the moment, seven medical sites are in charge of recruiting potential participants. These include Memorial Sloan Kettering Monmouth located in Middletown, Memorial Sloan Kettering Bergen at Montvale and the Memorial Slaon Kettering Cancer Center @ Suffolk - Commack based in Commack; along with four other locations."

Answered by AI

Are there any potential risks associated with using Tibetree Pain Relieving Plaster?

"The safety of Tibetree Pain Relieving Plaster has been scored a 2 on our scale, as it is currently undergoing Phase 2 trials. This signifies that there are some data points affirming its security but none proving its effectiveness."

Answered by AI

Are there any vacancies available for prospective participants in this trial?

"This research project, which was initially posted on May 28th 2021 and later edited in October 21st 2022 is not presently enrolling patients. Nevertheless, 487 other medical trials are actively searching for participants at this time."

Answered by AI
~2 spots leftby May 2024